TELDAY-R
Brand:
TELDAY-R
Manufacturer:
TORRENT
Manufacturer Details
TORRENT
Compositions:
Telmistratan 40mg,
Ramipril 5mg tablets,
|
Strength
|
Rate
|
Packing Style
|
|
40mg + 5mg
|
0.00
|
10s tablets
|
List of Related Indications:
List Of Drugs:
- Telmisartan + Ramipril - Angotensin II Antagonists Combination
Indication Type Description:
Indication:
Hypertension
INFORMATION UPDATE
TELMISARTAN + RAMIPRIL - HARMFUL
In a very large trial( ONTARGET) involving 25.620 subjects has found that patients receiving the combination of an Angiotensin II Receptor Antagonist Blocker ( Telmisartan ) and an ACE inhibitor (Ramipril ) did not obtain any benefit in the end points of the cardiovascular death, MI, stroke and heart failure compared to monotherapy, but experienced an increased incidence of clinically important renal dysfunction ( death , doubling of serum creatinine or dialysis ) compared with groups receiving talmisartan alone or ramipril alone.
Therefore concomittant use of telmisartan and ramipril is not recommended. ( MIMS )
Dosages/ Overdosage Etc:
Indication
Hypertension
Dosage-
1 tablet daily
